Success Metrics

Clinical Success Rate

66.7%

Based on 4 completed trials

Completion Rate

67%(4/6)

Active Trials

1(14%)

Results Posted

50%(2 trials)

Terminated

2(29%)

Phase Distribution

Ph not_applicable

14%

Ph phase_3

14%

Ph phase_4

14%

Ph phase_2

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

2(40.0%)

Phase 3Large-scale testing

1(20.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(2)

Detailed Status

Completed4

Terminated2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 22 (40.0%)

Phase 31 (20.0%)

Phase 41 (20.0%)

N/A1 (20.0%)

Trials by Status

recruiting114%

completed457%

terminated229%

Recent Activity

1 active trials

Showing 5 of 7

recruitingphase_4

PErsonalized Addition of Recombinant LH in Ovarian Stimulation

NCT04719000

completed

Observational Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Techniques in Spain.

NCT02941341

completed

Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Technology

NCT02942849

terminatedphase_2

A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

NCT01079949

completedphase_2

A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women

NCT01735422

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT04719000Phase 4

PErsonalized Addition of Recombinant LH in Ovarian Stimulation

Recruiting

NCT02941341

Observational Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Techniques in Spain.

Completed

NCT02942849

Post-Authorisation Study on the Use of Bemfola® in Human Assisted Reproductive Technology

Completed

NCT01079949Phase 2

A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age

Terminated

NCT01735422Phase 2

A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women

Completed

NCT01071200Phase 3

Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle

Terminated

NCT01223079Not Applicable

Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7